1,3,5-Trimethoxybenzene

DB15875InvestigationalSmall molecule

1,3,5-Trimethoxybenzene is a medication indicated for the symptomatic treatment of spastic pain of the urinary tract, renal colic, and painful disorders of the digestive and biliary tract.

Formula / weight: C₉H₁₂O₃ · 168.192 g/mol (avg)
Also known as: 1,3,5-Trimethyoxybenzene · Phloroglucinol trimethyl ether · sym-Trimethoxybenzene

Resolves to

Compound

UNII00VJI3VG3DCAS621-23-8ChEMBLCHEMBL1605492ChEBI31038

Clinical / RWD

RxNorm38716

Structure

InChIKeyLKUDPHPHKOZXCD-UHFFFAOYSA-NSMILESCOC1=CC(OC)=CC(OC)=C1

What you can answer from here — as of March 06, 2025

1ContraindicationEach with its own population and attribute set

2Marketed productsAcross 1 country and 1 labeller

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of 1,3,5-Trimethoxybenzene, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account